XSTAT 30, a hemostatic device for the treatment of severe bleeding in the axilla or groin area, was cleared for use in both battlefield and civilian trauma settings by the U.S. Food and Drug Administration.
The clearance expands the device’s indication from use by the military only to use in adults and adolescents in the general population.
XSTAT 30 by RevMedx works by injecting a group of small, rapidly-expanding sponges into a wound cavity using a syringe-like applicator.